ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,387.86
0.08%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. PainReform Ltd (PRFX) Share Price

PRFX PainReform Ltd

0.63
-0.031 (-4.69%)
07 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 PainReform Ltd NASDAQ:PRFX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.031 -4.69 0.63 0.603 0.70 0.698 0.60 0.698 60,654 22:06:47   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -9.34M -5.4063 -0.12 1.09M
 Type  Size  Price  Time  Units 
 9 3 0.6636 20:38:46 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore PRFX News
31/05/202421:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
31/05/202421:15GLOBEPainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
15/05/202421:05GLOBEPainReform Provides Business Update for the First Quarter of 2024
08/05/202413:30GLOBEPainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com
18/04/202419:19GLOBEPainReform Announces Closing of $4 Million Public Offering
16/04/202413:00GLOBEPainReform Announces Pricing of $4 Million Public Offering
09/04/202414:00GLOBEPainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
Period
Draw mode
Data Downloads for PRFX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest PainReform Ltd Articles